Dual-acting compounds that deliver an acidifying domain via zanamivir to the virus surface are potent influenza inhibitors
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Here we present a new approach to drug design that utilizes compounds devised to alter the microenvironment of the virion surface making it incompatible with virus entry and illustrate this strategy with inhibitors of influenza virus.
Appeared: Sunday, November 8. Science Advances. Peer-reviewed journal.